Michael Härter

747 total citations
13 papers, 595 citations indexed

About

Michael Härter is a scholar working on Organic Chemistry, Oncology and Immunology and Allergy. According to data from OpenAlex, Michael Härter has authored 13 papers receiving a total of 595 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Organic Chemistry, 3 papers in Oncology and 3 papers in Immunology and Allergy. Recurrent topics in Michael Härter's work include Cell Adhesion Molecules Research (3 papers), Synthetic Organic Chemistry Methods (3 papers) and Asymmetric Synthesis and Catalysis (2 papers). Michael Härter is often cited by papers focused on Cell Adhesion Molecules Research (3 papers), Synthetic Organic Chemistry Methods (3 papers) and Asymmetric Synthesis and Catalysis (2 papers). Michael Härter collaborates with scholars based in Germany, United States and Japan. Michael Härter's co-authors include K. C. Nicolaou, Janet L. Gunzner, Alan Nadin, Hartmut Beck, Carsten Schmeck, Frank Wunder, Lee T. Boulton, Bernd Jandeleit, Cristina Alonso‐Alija and Claudia Hirth‐Dietrich and has published in prestigious journals such as British Journal of Pharmacology, Drug Discovery Today and European Journal of Medicinal Chemistry.

In The Last Decade

Michael Härter

13 papers receiving 582 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Härter Germany 10 314 176 60 50 42 13 595
James E. Sheppeck United States 15 296 0.9× 313 1.8× 37 0.6× 72 1.4× 72 1.7× 24 628
Lawrence A. Reiter United States 15 268 0.9× 358 2.0× 58 1.0× 48 1.0× 100 2.4× 32 697
Gregory R. Luedtke United States 11 253 0.8× 158 0.9× 54 0.9× 48 1.0× 58 1.4× 15 425
Barbara J. Haertlein United States 14 271 0.9× 270 1.5× 30 0.5× 63 1.3× 32 0.8× 24 734
Clive McCarthy United Kingdom 16 271 0.9× 255 1.4× 98 1.6× 55 1.1× 68 1.6× 29 673
Stefan Jaroch Germany 14 244 0.8× 228 1.3× 113 1.9× 74 1.5× 105 2.5× 24 843
Mark A. Collins United States 15 286 0.9× 182 1.0× 34 0.6× 45 0.9× 24 0.6× 24 610
Norbert Schmees Germany 11 288 0.9× 281 1.6× 63 1.1× 40 0.8× 112 2.7× 19 870
Laurence E. Burgess United States 15 563 1.8× 320 1.8× 73 1.2× 35 0.7× 68 1.6× 31 880
John L. Gilmore United States 14 323 1.0× 235 1.3× 14 0.2× 23 0.5× 71 1.7× 21 525

Countries citing papers authored by Michael Härter

Since Specialization
Citations

This map shows the geographic impact of Michael Härter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Härter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Härter more than expected).

Fields of papers citing papers by Michael Härter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Härter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Härter. The network helps show where Michael Härter may publish in the future.

Co-authorship network of co-authors of Michael Härter

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Härter. A scholar is included among the top collaborators of Michael Härter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Härter. Michael Härter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Härter, Michael, Martina Delbeck, Klemens Lustig, et al.. (2018). Novel non-xanthine antagonist of the A2B adenosine receptor: From HTS hit to lead structure. European Journal of Medicinal Chemistry. 163. 763–778. 11 indexed citations
3.
Härter, Michael, Karl‐Heinz Thierauch, Ajay Bhargava, et al.. (2013). Inhibition of Hypoxia‐Induced Gene Transcription by Substituted Pyrazolyl Oxadiazoles: Initial Lead Generation and Structure–Activity Relationships. ChemMedChem. 9(1). 61–66. 5 indexed citations
4.
Hirth‐Dietrich, Claudia, Cristina Alonso‐Alija, Michael Härter, et al.. (2011). Nitric Oxide-independent Activation of Soluble Guanylate Cyclase by BAY 60-2770 in Experimental Liver Fibrosis. Arzneimittelforschung. 58(2). 71–80. 70 indexed citations
5.
Wunder, Frank, Hanna Tinel, R. Kast, et al.. (2010). Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT2) receptor. British Journal of Pharmacology. 160(2). 399–409. 66 indexed citations
6.
Urbahns, Klaus, Michael Härter, Delf Schmidt, et al.. (2007). Biphenyls as potent vitronectin receptor antagonists. Part 3: Squaric acid amides. Bioorganic & Medicinal Chemistry Letters. 17(22). 6151–6154. 17 indexed citations
7.
Hirth‐Dietrich, Claudia, Cristina Alonso‐Alija, Michael Härter, et al.. (2005). Antifibrotic effects of an sGC activator in rat models of liver fibrosis. BMC Pharmacology. 5(S1). 3 indexed citations
8.
Urbahns, Klaus, Michael Härter, Andrea Vaupel, et al.. (2003). Biphenyls as potent vitronectin receptor antagonists. Part 2: biphenylalanine ureas. Bioorganic & Medicinal Chemistry Letters. 13(6). 1071–1074. 17 indexed citations
9.
Urbahns, Klaus, Michael Härter, Delf Schmidt, et al.. (2002). Biphenyls as potent vitronectin receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 12(2). 205–208. 19 indexed citations
10.
Grimme, Wolfram, et al.. (1999). The cheletropic ene-reaction and its reversal; additions to 1,2,3,4-tetrachloro-5-methylenecyclohexa-1,3-diene. Journal of the Chemical Society Perkin Transactions 2. 1959–1965. 4 indexed citations
11.
Nicolaou, K. C., Michael Härter, Janet L. Gunzner, & Alan Nadin. (1997). The Wittig and Related Reactions in Natural Product Synthesis. Liebigs Annalen. 1997(7). 1283–1301. 220 indexed citations
12.
Nicolaou, K. C., Michael Härter, Lee T. Boulton, & Bernd Jandeleit. (1997). Synthesis of the Bicyclic Core of CP‐225,917 and CP‐263,114 by an Intramolecular Diels–Alder Reaction. Angewandte Chemie International Edition in English. 36(11). 1194–1196. 37 indexed citations
13.
Nicolaou, K. C., Michael Härter, Lee T. Boulton, & Bernd Jandeleit. (1997). Synthese des bicyclischen Gerüstes von CP‐225,917 und CP‐263,114 durch intramolekulare Diels‐Alder‐Reaktion. Angewandte Chemie. 109(11). 1243–1245. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James E. Sheppeck Breakdown of academic impact, for papers by Lawrence A. Reiter Breakdown of academic impact, for papers by Gregory R. Luedtke Breakdown of academic impact, for papers by Barbara J. Haertlein Breakdown of academic impact, for papers by Clive McCarthy Breakdown of academic impact, for papers by Stefan Jaroch Breakdown of academic impact, for papers by Mark A. Collins Breakdown of academic impact, for papers by Norbert Schmees Breakdown of academic impact, for papers by Laurence E. Burgess Breakdown of academic impact, for papers by John L. Gilmore
Rankless by CCL
2026